Moods Disorders Completed Phase 3 Trials for Topiramate (DB00273)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00035802A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderTreatment
NCT00240721A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderTreatment